BlackRock Institutional Trust’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$11K Hold
687
﹤0.01% 3790
2016
Q3
$15K Sell
687
-1,061
-61% -$24.4K ﹤0.01% 3826
2016
Q2
$32K Sell
1,748
-12,869
-88% -$342K ﹤0.01% 3789
2016
Q1
$384K Sell
14,617
-608
-4% -$18.9K ﹤0.01% 3510
2015
Q4
$553K Buy
15,225
+590
+4% +$25.6K ﹤0.01% 3490
2015
Q3
$485K Buy
14,635
+1,525
+12% +$85.9K ﹤0.01% 3506
2015
Q2
$907K Sell
13,110
-1,418
-10% -$97.8K ﹤0.01% 3384
2015
Q1
$1.09M Buy
14,528
+438
+3% +$34.5K ﹤0.01% 3319
2014
Q4
$1.17M Sell
14,090
-328
-2% -$26.6K ﹤0.01% 3302
2014
Q3
$1.17M Sell
14,418
-1,121
-7% -$95.7K ﹤0.01% 3273
2014
Q2
$1.39M Buy
15,539
+5,321
+52% +$472K ﹤0.01% 3332
2014
Q1
$1.21M Sell
10,218
-54
-0.5% -$5.25K ﹤0.01% 3356
2013
Q4
$724K Sell
10,272
-1,322
-11% -$53.9K ﹤0.01% 3486
2013
Q3
$654K Buy
11,594
+458
+4% +$28.7K ﹤0.01% 3473
2013
Q2
$815K Buy
+11,136
New +$643K ﹤0.01% 3384

Other funds holding ALIM

BlackRock Institutional Trust's ALIM Position: Q4 2016 in Review

BlackRock Institutional Trust held its Alimera Sciences (ALIM) position steady in Q4 2016 at 687 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #3790.

BlackRock Institutional Trust first reported a position in ALIM in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.39M in Q2 2014. 47 funds tracked by Wall St. Rank hold ALIM as of Q4 2016.

  • BlackRock Institutional Trust held 687 shares of Alimera Sciences worth $11K as of Q4 2016.
  • BlackRock Institutional Trust left its Alimera Sciences share count unchanged in Q4 2016.
  • Alimera Sciences made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3790 holding.
  • BlackRock Institutional Trust first reported a position in Alimera Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Alimera Sciences position peaked at $1.39M in Q2 2014.
  • 47 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.